Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Principal Investigator
Name
Paramita Saha-Chaudhuri
Degrees
Ph.D.
Institution
McGill University
Position Title
Associate Professor
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-408
Initial CDAS Request Approval
Oct 12, 2018
Title
Monitoring with Repeatedly Measured Markers: Application to longitudinal PSA measurements in PLCO
Summary
This is a statistical methodologic project for publication in a statistical journal. We request the data as an example to apply our new methodology. We propose a new measure of time-dependent prediction accuracy, called the Overall Detection Rate (ODR), and use the ODR curve to assess incremental value of additional marker measurements. The advantage of ODR is that it fixes the false-positive rate over time, rather than fixing a marker value threshold over time. For markers like PSA that naturally increase with age, any reasonable PSA threshold will be exceeded by nearly everyone who is old enough. However, by fixing the false-positive rate (which means the PSA threshold will implicitly increase with age), we obtain a more reasonable measure of time-dependent prediction accuracy.
Aims

1. Study the statistical properties of the new ODR estimator by extensive simulations.
2. Develop a model for longitudinal PSA data over age from PLCO, and calculate and compare all metrics of time-dependent prediction accuracy, including ODR.

Collaborators

Hormuzd Katki: Division of Cancer Epidemiology and Genetics, NCI/NIH